Duality Advisers, LP Ironwood Pharmaceuticals Inc Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$8.32 - $15.45 $49,312 - $91,572
-5,927 Reduced 9.14%
58,915 $513,000
Q4 2023

Feb 01, 2024
SELL
$8.79 - $11.51 $78,811 - $103,198
-8,966 Reduced 12.15%
64,842 $741,000
Q3 2023

Nov 02, 2023
BUY
$8.25 - $11.35 $301,488 - $414,774
36,544 Added 98.07%
73,808 $710,000
Q2 2023

Jul 31, 2023
BUY
$10.1 - $11.6 $34,875 - $40,054
3,453 Added 10.21%
37,264 $396,000
Q1 2023

Jun 27, 2023
SELL
$10.37 - $12.56 $427,223 - $517,446
-41,198 Reduced 54.92%
33,811 $355,000
Q4 2022

Feb 07, 2023
SELL
$9.9 - $12.43 $1 Million - $1.26 Million
-101,239 Reduced 57.44%
75,009 $929,000
Q3 2022

Nov 03, 2022
BUY
$10.14 - $12.38 $1.24 Million - $1.52 Million
122,504 Added 227.94%
176,248 $1.83 Million
Q2 2022

Aug 08, 2022
BUY
$11.05 - $12.72 $418,065 - $481,248
37,834 Added 237.8%
53,744 $620,000
Q1 2022

May 09, 2022
BUY
$10.61 - $12.88 $168,805 - $204,920
15,910 New
15,910 $200,000
Q1 2021

May 13, 2021
SELL
$9.04 - $11.86 $1.29 Million - $1.69 Million
-142,346 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$9.05 - $12.2 $192,547 - $259,567
21,276 Added 17.57%
142,346 $1.62 Million
Q3 2020

Nov 12, 2020
BUY
$8.99 - $10.74 $1.09 Million - $1.3 Million
121,070 New
121,070 $1.09 Million

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $527M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email